A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.

Pedersen, N; Schmitt, M; Rønne, E; Nicoletti, M I; Høyer-Hansen, G; Conese, M; Giavazzi, R; Dano, K; Kuhn, W; Jänicke, F

Pedersen, N; Schmitt, M; Rønne, E; Nicoletti, M I; Høyer-Hansen, G; Conese, M; Giavazzi, R; Dano, K; Kuhn, W; Jänicke, F.

Affiliation

Pedersen N; Institute of Microbiology, University of Copenhagen, Denmark.

J Clin Invest ; 92(5): 2160-7, 1993 Nov.

Article in En | MEDLINE | ID: mdl-8227331

Subject(s)

Ascitic Fluid/chemistry; Carcinoma/chemistry; Ovarian Neoplasms/chemistry; Receptors, Cell Surface/isolation & purification; Urokinase-Type Plasminogen Activator/metabolism; Animals; Female; Glycoproteins/isolation & purification; Glycoproteins/metabolism; Humans; Ligands; Mice; Mice, Nude; Neoplasm Transplantation; Receptors, Cell Surface/metabolism; Receptors, Urokinase Plasminogen Activator; Solubility; Transplantation, Heterologous

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Ascitic Fluid / Carcinoma / Urokinase-Type Plasminogen Activator / Receptors, Cell Surface Limits: Animals / Female / Humans Language: En Journal: J Clin Invest Year: 1993 Type: Article Affiliation country: Denmark

Fulltext

XML

PubMed Links

Search on Google